Oral mucosal changes induced by anticancer targeted therapies and immune checkpoint inhibitors.

Oral mucosal changes induced by anticancer targeted therapies and immune checkpoint inhibitors.

Item
http://www.wikidata.org/entity/Q38948950
Future trends and emerging issues for nanodelivery systems in oral and oropharyngeal cancerCombination of melatonin and rapamycin for head and neck cancer therapy: Suppression of AKT/mTOR pathway activation, and activation of mitophagy and apoptosis via mitochondrial function regulation.Immune Checkpoints in Leprosy: Immunotherapy As a Feasible Approach to Control Disease Progression.Dermatologic Reactions to Immune Checkpoint Inhibitors : Skin Toxicities and Immunotherapy.Management of radiation-induced mucosal necrosis with photobiomodulation therapy.Oral lichenoid reactions associated with anti-PD-1/PD-L1 therapies: clinicopathological findings.Stomatitis and VEGFR-Tyrosine Kinase Inhibitors (VR-TKIs): A Review of Current Literature in 4369 Patients.Could the Combined Administration of Bone Antiresorptive Drug, Taxanes, and Corticosteroids Worsen Medication Related Osteonecrosis of the Jaws in Cancer Patients?
P2860

Oral mucosal changes induced by anticancer targeted therapies and immune checkpoint inhibitors.

Item
http://www.wikidata.org/entity/Q38948950
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Oral mucosal changes induced b ...... immune checkpoint inhibitors.
@en
type
label
Oral mucosal changes induced b ...... immune checkpoint inhibitors.
@en
prefLabel
Oral mucosal changes induced b ...... immune checkpoint inhibitors.
@en
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P433
P478
P577
P698
P356
P1433
P1476
Oral mucosal changes induced b ...... immune checkpoint inhibitors.
@en
P2093
P2860
P2888
P304
P31
P356
P433
P478
P577
P698